Objective To study the serum expression of interleukin-36α(IL-36α),C1q/tumor necrosis factor-related protein 6(CTRP6)levels in patients with polycystic ovary syndrome(PCOS)and their diagnostic value.Methods A total of 98 PCOS patients diagnosed and treated in the Fifth Affiliated Hospital of Xinjiang Medical University from April 2019 to April 2022 were taken as the PCOS group,and 70 healthy women were taken as the control group.Enzyme-linked immunosorbent assay was applied to detect serum IL-36 α and CTRP6 level expression.The correlation between the expression of serum IL-36 α,CTRP6 levels and clinical indicators was analyzed by Pearson correlation analysis.Multivariate logistic regression analysis was used to analyze factors affecting the occurrence of PCOS.Receiver operating characteristic curve was used to evaluate the diagnostic efficacy of serum IL-36α,CTRP6 and combination in PCOS.Results Serum CTRP6(18.25±3.67μg/L),FPG(5.71±0.49nmol/L),FINS(18.96±2.68mIU/L),HOMA-IR(4.72±0.46),LH(6.17±1.44IU/L),T(1.32±0.42nmol/L),ovarian number(17.86±5.20)and ovarian volume(9.29±2.14cm3)in the PCOS group were higher,while serum IL-36 α(0.67±0.13ng/L)and FSH((4.27±1.33IU/L)were lower compared with those in the control group(5.14±1.28μg/L,4.76±0.54mmol/L,8.63±1.65mIU/L,1.83±0.33,4.92±1.39IU/L,0.86±0.28nmol/L,6.76±1.94 个,5.26±1.31cm3,2.11±0.38ng/L,5.42±1.67IU/L),with significant differences(t/x2=4.962～44.934,all P<0.05).Serum IL-36α(0.87±0.15ng/L,0.70±0.12ng/L,0.51±0.11ng/L,0.42±0.10ng/L)levels in patients with type 1,type 2,type 3,and type 4 PCOS were decreased sequentially,while CTRP6(14.07±3.35 μg/L,17.66±3.97 μg/L,21.16±3.67 μg/L,24.08±3.53 μg/L)were increased sequentially,with significant differences(F=61.281,33.854,all P<0.05).There was a negative correlation between serum IL-36 α and ovarian number,ovarian volume,FINS and HOMA-IR(r=-0.661,-0.621,-0.554,-0.671,all P<0.05).Serum CTRP6 was positively correlated with ovarian number,ovarian volume,FINS and HOMA-IR(r=0.625,0.631,0.537,0.738,all P<0.05).CTRP6(OR=1.327,95%CI:1.104～1.596)was an independent risk factor affecting the occurrence of PCOS,while IL-36 α(OR=0.707,95%CI:0.547～0.914)was a protective factor.The area under the curve(95%CI)of combination of IL-36 α and CTRP6 for the diagnosis of PCOS was 0.933(0.872～0.969),which was greater than that of IL-36 α,CTRP6 alone[0.870(0.821～0.926),0.898(0.854～0.940)],with significant differences(Z=4.258,4.119,all P<0.05).Conclusion The decrease of serum IL-36α and the increase of CTRP6 in PCOS patients are related to the severity of PCOS,and the combined detection of the two may have high diagnostic value for PCOS.

AIM:To investigate the effect and mechanism of velvet antler polypeptide(VAP)on premature ovarian failure induced by cisplatin(DDP)in rats.METHODS:Female rats with normal estrous cycle were randomly di-vided into the control,model,and VAP groups,with 10 rats in each group.Premature ovarian failure was induced in the model and VAP groups by intraperitoneal injection of DDP(4 mg·kg-1·d-1)for 20 consecutive days,and the VAP group was treated with VAP(400 mg·kg-1·d-1)for 20 consecutive days.Hematoxylin and eosin(HE)staining was used to ob-serve the morphological manifestations of the ovary,and the number of developing follicles at all levels was counted.En-zyme-linked immunosorbent assay(ELISA)was performed to detect serum estradiol(E2),follicle-stimulating hormone(FSH),and anti-Mullerian hormone(AMH)levels.The levels of glutathione(GSH)and malondialdehyde(MDA)in ovarian tissues were detected by biochemical methods.The level of reactive oxygen species(ROS)in ovarian tissue was detected by the probe labeling method.Prussian blue staining was performed to observe the iron accumulation in ovarian tissue,as well as the ferrous ion(Fe2+)level was detected by Fe2+content analysis kit.Immunohistochemistry and West-ern blot analysis were performed to detect the expressions of solute carrier family 7 member 11(SCL7A11),glutathione peroxidase 4(GPX4),and acyl-CoA synthetase long-chain family member 4(ACSL4)in the ovarian tissue.The fertility of rats was monitored in each group.RESULTS:Compared with control group,the model group showed ovarian atrophy,iron accumulation(P<0.01),reduced development of follicles at all levels and total follicles(P<0.05),increased atretic follicles(P<0.01),reduced litter size(P<0.01),decreased serum E2 and AMH levels(P<0.01),increased FSH levels(P<0.01),decreased GSH level and SCL7A11 and GPX4 protein expression levels in the ovarian tissue(P<0.01),and increased levels of Fe2+,MDA,and ROS and expression levels of ACSL4(P<0.01).Compared with model group,the VAP group had improvement in these aforementioned changes caused by DDP(P<0.01).CONCLUSION:Treatment with VAP can improve ovarian function,maintain normal follicle development,and improve fertility in cisplatin-induced premature ovarian failure rats,and the mechanism may be related to the inhibition of lipid peroxidation and ferroptosis.